BFG
Bleakley Financial Group Portfolio holdings
AUM
$3.94B
This Quarter Return
+2.26%
1 Year Return
+21.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.32B
AUM Growth
+$3.32B
(+1.3%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
2.29%
Top 10 Holdings %
Top 10 Hldgs %
29.32%
Holding
1,117
New
85
Increased
510
Reduced
412
Closed
74
Top Buys
Top Sells
| 1 |
Vanguard Large-Cap ETF
VV
|
$21.9M |
| 2 |
Vanguard Mid-Cap ETF
VO
|
$11.9M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$7.73M |
| 4 |
ProShares UltraPro QQQ
TQQQ
|
$4.28M |
| 5 |
ORAN
Orange
ORAN
|
$3.7M |
Sector Composition
| 1 | Technology | 16.48% |
| 2 | Financials | 6.69% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
TETRA Technologies
TTI
$626M
| $68.7K | ﹤0.01% |
19,200
+151
| +0.8% | +$541 |
|
1002
Waldencast
WALD
$192M
| $68.6K | ﹤0.01% |
17,064
-9,233
| -35% | -$37.1K |
|
1003
Compass
COMP
$4.77B
| $67.1K | ﹤0.01% |
11,475
-1,258
| -10% | -$7.36K |
|
1004
Liberty Latin America Class C
LILAK
$1.65B
| $64.9K | ﹤0.01% |
+10,237
| New | +$64.9K |
|
1005
Clover Health Investments
CLOV
$1.34B
| $63K | ﹤0.01% |
20,000
-90
| -0.4% | -$284 |
|
1006
Safe Bulkers
SB
$435M
| $61.8K | ﹤0.01% |
17,305
-3,207
| -16% | -$11.4K |
|
1007
Olaplex Holdings
OLPX
$954M
| $60.8K | ﹤0.01% |
35,133
-1,082
| -3% | -$1.87K |
|
|
JMIA
1008
Jumia Technologies
JMIA
$1.05B
| $59.8K | ﹤0.01% |
15,650
| – | – |
|
1009
Nokia
NOK
$23.1B
| $59.4K | ﹤0.01% |
13,418
-162
| -1% | -$718 |
|
1010
Compass Therapeutics
CMPX
$483M
| $58K | ﹤0.01% |
39,993
+28,589
| +251% | +$41.5K |
|
1011
Crexendo
CXDO
$191M
| $57.5K | ﹤0.01% |
11,000
| – | – |
|
1012
Vaalco Energy
EGY
$405M
| $56.3K | ﹤0.01% |
12,885
+387
| +3% | +$1.69K |
|
1013
Ventyx Biosciences
VTYX
$171M
| $50.6K | ﹤0.01% |
23,083
+971
| +4% | +$2.13K |
|
1014
Definitive Healthcare
DH
$419M
| $50.3K | ﹤0.01% |
12,233
-4,415
| -27% | -$18.1K |
|
1015
Lloyds Banking Group
LYG
$64.3B
| $50K | ﹤0.01% |
18,392
+2,619
| +17% | +$7.12K |
|
1016
Lotus Technology
LOT
$1.44B
| $48.3K | ﹤0.01% |
+13,376
| New | +$48.3K |
|
|
DHC
1017
Diversified Healthcare Trust
DHC
$920M
| $41.7K | ﹤0.01% |
18,140
-602
| -3% | -$1.39K |
|
1018
OmniAb
OABI
$230M
| $39.8K | ﹤0.01% |
11,229
-8,259
| -42% | -$29.2K |
|
1019
Tango Therapeutics
TNGX
$747M
| $39.7K | ﹤0.01% |
12,849
-1,578
| -11% | -$4.88K |
|
1020
Accuray
ARAY
$157M
| $39.3K | ﹤0.01% |
19,833
| – | – |
|
1021
Precigen
PGEN
$1.34B
| $39.1K | ﹤0.01% |
34,888
-332
| -0.9% | -$372 |
|
1022
ImmunityBio
IBRX
$2.21B
| $36.1K | ﹤0.01% |
14,095
-1,848
| -12% | -$4.73K |
|
1023
Esperion Therapeutics
ESPR
$448M
| $36K | ﹤0.01% |
16,357
| – | – |
|
1024
Xeris Biopharma Holdings
XERS
$1.26B
| $35.7K | ﹤0.01% |
10,536
-580
| -5% | -$1.97K |
|
1025
AXT Inc
AXTI
$134M
| $29.3K | ﹤0.01% |
+13,500
| New | +$29.3K |
|